tiprankstipranks
Trending News
More News >
Immunocore Holdings (IMCR)
NASDAQ:IMCR
US Market

Immunocore Holdings (IMCR) Financial Statements

Compare
239 Followers

Immunocore Holdings Financial Overview

Immunocore Holdings's market cap is currently $1.67B. The company's EPS TTM is $0; its P/E ratio is -56.49; Immunocore Holdings is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue£ 247.77M£ 249.43M£ 144.23M£ 36.48M£ 30.11M
Gross Profit£ 239.38M£ 248.39M£ 138.94M£ 36.48M£ -44.70M
Operating Income£ -56.28M£ -59.65M£ -42.77M£ -174.59M£ -86.19M
EBITDA£ -38.50M£ -51.65M£ -38.35M£ -166.72M£ -82.38M
Net Income£ -40.81M£ -55.29M£ -43.46M£ -180.03M£ -74.09M
Balance Sheet
Cash & Short-Term Investments£ 820.38M£ 442.63M£ 402.47M£ 321.06M£ 176.78M
Total Assets£ 1.01B£ 597.00M£ 526.76M£ 407.28M£ 197.19M
Total Debt£ 432.72M£ 84.03M£ 81.45M£ 86.16M£ 74.47M
Net Debt£ -23.01M£ -358.59M£ -321.02M£ -234.90M£ -102.31M
Total Liabilities£ 648.79M£ 228.16M£ 187.86M£ 175.76M£ 141.85M
Stockholders' Equity£ 360.72M£ 368.84M£ 338.90M£ 231.53M£ 55.35M
Cash Flow
Free Cash Flow£ 20.89M£ -2.48M£ -51.41M£ -144.49M£ -63.65M
Operating Cash Flow£ 26.06M£ 2.94M£ -49.21M£ -143.11M£ -60.57M
Investing Cash Flow£ -355.13M£ -5.42M£ -2.20M£ -1.28M£ 467.00K
Financing Cash Flow£ 343.88M£ 34.35M£ 145.44M£ 288.19M£ 115.94M
Currency in GBP

Immunocore Holdings Earnings and Revenue History

Immunocore Holdings Debt to Assets

Immunocore Holdings Cash Flow

Immunocore Holdings Forecast EPS vs Actual EPS